This inventor holds 5 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Merck + Co., Inc., Merck Sharp + Dohme Corp.. Active years: 2000-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2000-2014
Title: The Innovative Mind of Stanley F. Barnett
Introduction
Stanley F. Barnett, an accomplished inventor located in North Wales, PA, has made significant contributions to the field of biotechnology. With a total of five patents to his name, Barnett has demonstrated a profound understanding of complex chemical and biological interactions, particularly in the development of oligonucleotide delivery systems and cancer treatment.
Latest Patents
Among his most recent innovations, Barnett's patent titled "Single chemical entities and methods for delivery of oligonucleotides" reveals a novel modular composition. This composition includes an oligonucleotide, one or more linkers, and peptides that can be tailored to enhance therapeutic efficacy. The integration of lipids, solubilizing groups, and targeting ligands further enables precise delivery and action within biological systems.
Another notable patent, "Inhibitors of Akt activity," focuses on compounds featuring a triazolo[4,3-b]pyridazine moiety designed to inhibit the protein kinase Akt. This invention not only targets a critical pathway in cellular processes but also opens avenues for developing chemotherapeutic compositions aimed at treating various forms of cancer.
Career Highlights
Stanley F. Barnett has built a robust career in pharmaceutical innovation, having worked with prestigious organizations such as Merck & Company, Inc. and Merck Sharp & Dohme Corporation. These roles have equipped him with invaluable experience in both research and development, allowing him to contribute to groundbreaking advancements in the pharmaceutical industry.
Collaborations
Throughout his career, Barnett has collaborated with esteemed colleagues, including Andrew Pate Owens and Samuel L. Graham. These partnerships have been instrumental in fostering collaborative innovation, leading to successful projects that benefit the greater scientific community.
Conclusion
In summary, Stanley F. Barnett is a distinguished inventor whose work in oligonucleotide delivery and cancer treatment reflects his commitment to advancing medical technology. His five patents stand as a testament to his innovative capabilities and his impact on the field. As research continues to evolve, the contributions of inventors like Barnett will remain crucial in the pursuit of effective treatments and medical breakthroughs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile